Phase II Trial of Capecitabine and Weekly Docetaxel in Metastatic Renal Cell Carcinoma-Reference-Cited by-同舟云学术

Phase II Trial of Capecitabine and Weekly Docetaxel in Metastatic Renal Cell Carcinoma

Published:2008-10 Issue:4 Volume:72 Page:898-902
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Marur Shanthi,Eliason James,Heilbrun Lance K.,Dickow Brenda,Smith Daryn W.,Baranowski Karen,Alhasan Samir,Vaishampayan Ulka

Publisher

Elsevier BV

Subject

Urology

Reference29 articles.

1. Results of treatment of 255 patients with metastatic renal cell carcinoma who received high dose recombinant interleukin-2 therapy;Fyfe;J Clin Oncol,1995

2. Long term survival update for high dose recombinant interleukin-2 in patients with renal cell carcinoma;Fisher;Cancer J Sci Am,2000

3. Sunitinib versus interferon alfa in metastatic renal cell carcinoma;Motzer;N Engl J Med,2007

4. Sorafenib in advanced clear cell renal carcinoma;Escudier;N Engl J Med,2007

5. Phase II trial of interleukin-2, interferon alpha and 5-fluorouracil in metastatic renal cell cancer: A cytokine working Group study;Dutcher;Clin Cancer Res,2000

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elucidating the Influence of MPT-driven necrosis-linked LncRNAs on immunotherapy outcomes, sensitivity to chemotherapy, and mechanisms of cell death in clear cell renal carcinoma;Frontiers in Oncology;2023-12-15

2. Results From a Randomized Phase II Trial of Sunitinib and Gemcitabine or Sunitinib in Advanced Renal Cell Carcinoma with Sarcomatoid Features: ECOG-ACRIN E1808;Clinical Genitourinary Cancer;2023-10

3. Management of Non-Clear Cell Renal Cell Carcinoma;Renal Cancer;2019-10-17

4. The prospects for combination therapy with capecitabine in the rapidly evolving treatment landscape of renal cell carcinoma;Expert Opinion on Investigational Drugs;2018-01-24

5. Cytotoxic chemotherapy in the treatment of advanced renal cell carcinoma in the era of targeted therapy;Critical Reviews in Oncology/Hematology;2015-12